Shilpa Medicare Ltd Quarterly Result
Shilpa Medicare Ltd
NSE: SHILPAMED
Net Profit - Last Quarter
Shilpa Medicare Ltd Quarterly Results Key Highlights
- The revenue of Shilpa Medicare Ltd for the Mar '26 is ₹ 482 crore as compare to the Dec '25 revenue of ₹ 410.54 crore.
- This represent the growth of 17.41% The ebitda of Shilpa Medicare Ltd for the Mar '26 is ₹ 164.72 crore as compare to the Dec '25 ebitda of ₹ 101.89 crore.
- This represent the growth of 61.66% The net profit of Shilpa Medicare Ltd for the Mar '26 is ₹ 107.79 crore as compare to the Dec '25 net profit of ₹ 44.58 crore.
- This represent the growth of 141.79%.
Shilpa Medicare Ltd Quarterly Results Analysis
Market Price of Shilpa Medicare Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 31 Jul 2026 | 611.55 |
| 30 Jul 2026 | 603.6 |
| 29 Jul 2026 | 604.65 |
| 28 Jul 2026 | 605.3 |
| 27 Jul 2026 | 620.9 |
| 24 Jul 2026 | 607 |
| 23 Jul 2026 | 603.15 |
| 22 Jul 2026 | 613.45 |
| 21 Jul 2026 | 639.35 |
| 20 Jul 2026 | 625.6 |
Historical Revenue of Shilpa Medicare Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Shilpa Medicare Ltd
Historical EBITDA of Shilpa Medicare Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Shilpa Medicare Ltd
Historical Net Profit of Shilpa Medicare Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Shilpa Medicare Ltd
Shilpa Medicare Ltd News Hub
Shilpa Medicare to conduct AGM
Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will be held on
Read more
16 Aug 24
Shilpa Medicare consolidated net profit rises 1091.53% in the June 2024 quarter
Net profit of Shilpa Medicare rose 1091.53% to Rs 14.06 crore in the quarter ended June 2024 as agai
Read more
08 Aug 24
Shilpa Medicare to announce Quarterly Result
Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 August 2024. Power
Read more
02 Aug 24
Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA for Oxylanth
Read more
04 Sept 24
Document
Popular Search
About Shilpa Medicare Ltd
- Shilpa Medicare Limited, formerly known as Shilpa Antibiotics Private Limited was incorporated as a Private Company on November 20, 1987.
- The Company changed the status to Public and the name of the Company changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
- The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
- It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.
- It supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets.
